Vanguard Global Advisers »

Vyne Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $599 1.0k 0.60

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Vyne Therapeutics

Nantahala Capital Management
Lynx1 Capital Management
Shay Capital
Frigate Ventures
ADAR1 Capital Management
T3 Companies
Braidwell
Citadel Advisors
KVP Capital Advisors
Two Sigma Investments
Acadian Asset Management
Geode Capital Management
Vanguard Group
Ikarian Capital
Vanguard Capital Management

View all funds holding Vyne Therapeutics